Categorized: Abstracts & Presentations, Urology
How often does ERG contribute to resolving an “Atypical Glands Suspicious for Cancer” diagnosis in prostate biopsies beyond that provided by basal cell and Alpha-Methylacyl-CoA-Racemase (AMACR) markers?
Presentation given to the United States and Canadian Academy of Pathology’s 2012 Annual Meeting in Vancouver, BC, Canada.
For a copy, please contact Inform Diagnostics.